Faculty and Trainers

Emily Rogalski, PhD

  • Rosalind Franklin PhD Professor of Neurology
    Professor of Neuroscience Institute
    Committee on Neurobiology
  • Research and Scholarly Interests: Aging Well, Aging, Healthy, Alzheimer Dementia, Alzheimer Disease, Behavoiral intervention, Caregiver, Cognitive Functions, Communication, Partner, Community Health, Frontotemporal Dementia, Magnetic Resonance Imaging, Neurology, Neuropsychology, Neuroscience, Positron Emission Tomography, Primary Progressive Aphasia, Randomized Controlled Trial, Social Work, Speech Language Pathology, SuperAging
  • Websites: Healthy Aging & Alzheimer's Research Care Center, Research Network Profile
  • Contact: erogalski@uchicago.edu
  • Graduate Programs: Neurobiology, PhD Program in Neurobiology

Telephone-based Hopkins Verbal Learning Test-Revised as a pre-screening tool for identifying SuperAgers.
Telephone-based Hopkins Verbal Learning Test-Revised as a pre-screening tool for identifying SuperAgers. Arch Clin Neuropsychol. 2026 Sep 09; 41(7).
PMID: 42715377

Lessons From the Communication Bridge Trials: Advancing Meaningful Dyadic Interventions Toward Implementation.
Lessons From the Communication Bridge Trials: Advancing Meaningful Dyadic Interventions Toward Implementation. J Speech Lang Hear Res. 2026 Oct 13; 69(10):4615-4624.
PMID: 42709848

Care Partner Perceptions of Conversation Difficulties, Strategy Use, and Psychosocial Impacts in Primary Progressive Aphasia: A Descriptive Study Using the PCI-DAT.
Care Partner Perceptions of Conversation Difficulties, Strategy Use, and Psychosocial Impacts in Primary Progressive Aphasia: A Descriptive Study Using the PCI-DAT. Brain Sci. 2026 Aug 31; 16(9).
PMID: 42793362

Psychological well-being in cognitively intact adults aged 80+: Findings from the SuperAging Research Initiative.
Psychological well-being in cognitively intact adults aged 80+: Findings from the SuperAging Research Initiative. Front Psychol. 2026; 17:1819539.
PMID: 42718493

EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker.
EOAD-Signature Atrophy Predicts Dementia in Early-Onset MCI due to Alzheimer Disease: An MRI-Based Prognostic Biomarker. Neurology. 2026 Oct 13; 107(7):e218519.
PMID: 42647766

SuperAging is not the inverse of common-variant Alzheimer's risk: evidence across genetic ancestries.
SuperAging is not the inverse of common-variant Alzheimer's risk: evidence across genetic ancestries. Alzheimers Res Ther. 2026 Jul 23; 18(1).
PMID: 42493810

Relationships of CSF biomarkers to cortical atrophy in early-onset Alzheimer's disease.
Relationships of CSF biomarkers to cortical atrophy in early-onset Alzheimer's disease. Alzheimers Dement. 2026 Jul; 22(7):e71479.
PMID: 42477860

Person-centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge-2 randomized clinical trial.
Person-centered intervention response in primary progressive aphasia: A secondary analysis of the Communication Bridge-2 randomized clinical trial. Alzheimers Dement (N Y). 2026 Apr-Jun; 12(2):e70283.
PMID: 42358427

Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease.
Tau topography subtypes account for clinical heterogeneity and longitudinal trajectories in early-onset Alzheimer's disease. Brain Commun. 2026; 8(3):fcag176.
PMID: 42255923

Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS.
Criterion and convergent validity of plasma biomarkers in early-onset Alzheimer's disease: Initial findings from LEADS. Alzheimers Dement (Amst). 2026 Apr-Jun; 18:e70342.
PMID: 42088846

View All Publications